Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modigraf (tacrolimus granules) in pediatric liver and kidney transplant recipients
CTR20212679Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2021
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in graft rejection, sponsored by Astellas Pharma. Started Oct 2021; status: completed.
02
Drugs
tacrolimus
03
Conditions
graft rejection
Beyond the preview
Go deeper on CTR20212679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212679.